Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China

PLoS One. 2014 May 21;9(5):e98257. doi: 10.1371/journal.pone.0098257. eCollection 2014.

Abstract

Background/aim: To investigate the roles of mutations in pre-S and S regions of hepatitis B virus (HBV) on the progression of hepatocellular carcinoma (HCC) in Qidong, China.

Methods: We conducted an age matched case-control study within a cohort of 2387 male HBV carriers who were recruited from August, 1996. The HBV DNA sequence in pre-S/S regions was successfully determined in 96 HCC cases and 97 control subjects. In addition, a consecutive series of samples from 11 HCC cases were employed to evaluate the pre-S deletion patterns before and after the occurrence of HCC.

Results: After adjustment for age, history of cigarette smoking and alcohol consumption, HBeAg positivity, pre-S deletions, pre-S2 start codon mutations, and T53C mutation were significantly associated with HCC, showing adjusted odds ratios (ORs) from 1.914 to 3.199. HCC patients also had a lower frequency of T31C mutation in pre-S2 gene, compared with control subjects (0.524; 95% CI 0.280-0.982). HBV pre-S deletions were clustered mainly in the 5' end of pre-S2 region. Multivariate analysis showed that pre-S deletions and pre-S2 start codon mutations were independent risk factors for HCC. The OR (95% CI) were 2.434 (1.063-5.573) and 3.065 (1.099-8.547), respectively. The longitudinal observation indicated that the pre-S deletion mutations were not acquired at the beginning of HBV infection, but that the mutations occurred during the long course of liver disease.

Conclusion: Pre-S deletions and pre-S2 start codon mutations were independently associated with the development of HCC. The results also provided direct evidence that pre-S deletion mutations were not acquired from the beginning of infection but arose de novo during the progression of liver disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / virology*
  • Case-Control Studies
  • China
  • Codon, Initiator
  • Cohort Studies
  • Disease Progression
  • Gene Deletion*
  • Genotype
  • Hepatitis B / complications
  • Hepatitis B / virology*
  • Hepatitis B Surface Antigens / genetics
  • Hepatitis B virus / genetics*
  • Humans
  • Liver Neoplasms / pathology
  • Liver Neoplasms / virology*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Mutation
  • Sequence Deletion
  • Smoking

Substances

  • Codon, Initiator
  • Hepatitis B Surface Antigens

Grants and funding

The study was financially supported by the China Ministry of Health (W201202), Natural Science Foundation of Jiangsu Province (BK2012225), Foundation of Jiangsu Province (WS056), and National Nature Science Foundation of China (No. 81302056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.